These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2686 related articles for article (PubMed ID: 17062137)
1. Alpha-actinin-binding antibodies in relation to systemic lupus erythematosus and lupus nephritis. Becker-Merok A; Kalaaji M; Haugbro K; Nikolaisen C; Nilsen K; Rekvig OP; Nossent JC Arthritis Res Ther; 2006; 8(6):R162. PubMed ID: 17062137 [TBL] [Abstract][Full Text] [Related]
2. Cross-reactivity of human lupus anti-DNA antibodies with alpha-actinin and nephritogenic potential. Zhao Z; Weinstein E; Tuzova M; Davidson A; Mundel P; Marambio P; Putterman C Arthritis Rheum; 2005 Feb; 52(2):522-30. PubMed ID: 15693007 [TBL] [Abstract][Full Text] [Related]
3. Anti-chromatin and anti-C1q antibodies in systemic lupus erythematosus compared to other systemic autoimmune diseases. Braun A; Sis J; Max R; Mueller K; Fiehn C; Zeier M; Andrassy K Scand J Rheumatol; 2007; 36(4):291-8. PubMed ID: 17763207 [TBL] [Abstract][Full Text] [Related]
4. Association of alpha-actinin-binding anti-double-stranded DNA antibodies with lupus nephritis. Renaudineau Y; Croquefer S; Jousse S; Renaudineau E; Devauchelle V; Guéguen P; Hanrotel C; Gilburd B; Saraux A; Shoenfeld Y; Putterman C; Youinou P Arthritis Rheum; 2006 Aug; 54(8):2523-32. PubMed ID: 16868973 [TBL] [Abstract][Full Text] [Related]
5. The ananti-alpha-actinin test completes ananti-DNA determination in systemic lupus erythematosus. Croquefer S; Renaudineau Y; Jousse S; Gueguen P; Ansart S; Saraux A; Youinou P Ann N Y Acad Sci; 2005 Jun; 1050():170-5. PubMed ID: 16014531 [TBL] [Abstract][Full Text] [Related]
6. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis? Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329 [TBL] [Abstract][Full Text] [Related]
7. Anti-telomere antibodies in systemic lupus erythematosus (SLE): a comparison with five antinuclear antibody assays in 430 patients with SLE and other rheumatic diseases. Salonen EM; Miettinen A; Walle TK; Koskenmies S; Kere J; Julkunen H Ann Rheum Dis; 2004 Oct; 63(10):1250-4. PubMed ID: 15361381 [TBL] [Abstract][Full Text] [Related]
8. Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies. Pradhan VD; Patwardhan MM; Ghosh K Indian J Dermatol Venereol Leprol; 2010; 76(2):145-9. PubMed ID: 20228543 [TBL] [Abstract][Full Text] [Related]
9. Critical comparative analyses of anti-alpha-actinin and glomerulus-bound antibodies in human and murine lupus nephritis. Kalaaji M; Sturfelt G; Mjelle JE; Nossent H; Rekvig OP Arthritis Rheum; 2006 Mar; 54(3):914-26. PubMed ID: 16508974 [TBL] [Abstract][Full Text] [Related]
10. Anti-alpha-actinin antibodies: a new marker of lupus nephritis. Renaudineau Y; Deocharan B; Jousse S; Renaudineau E; Putterman C; Youinou P Autoimmun Rev; 2007 Aug; 6(7):464-8. PubMed ID: 17643934 [TBL] [Abstract][Full Text] [Related]
11. Presence of antinucleosome autoantibodies in a restricted set of connective tissue diseases: antinucleosome antibodies of the IgG3 subclass are markers of renal pathogenicity in systemic lupus erythematosus. Amoura Z; Koutouzov S; Chabre H; Cacoub P; Amoura I; Musset L; Bach JF; Piette JC Arthritis Rheum; 2000 Jan; 43(1):76-84. PubMed ID: 10643702 [TBL] [Abstract][Full Text] [Related]
12. BioPlex 2200 multiplexed system: simultaneous detection of anti-dsDNA and anti-chromatin antibodies in patients with systemic lupus erythematosus. Bardin N; Desplat-Jego S; Daniel L; Jourde Chiche N; Sanmarco M Autoimmunity; 2009 Jan; 42(1):63-8. PubMed ID: 19127456 [TBL] [Abstract][Full Text] [Related]
13. Prevalence of antinucleosome antibodies by enzyme-linked immunosorbent assays in patients with systemic lupus erythematosus and other autoimmune systemic diseases. Půtová I; Dostal C; Becvar R Ann N Y Acad Sci; 2007 Aug; 1109():275-86. PubMed ID: 17785316 [TBL] [Abstract][Full Text] [Related]
14. Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement. Oelzner P; Deliyska B; Fünfstück R; Hein G; Herrmann D; Stein G Clin Rheumatol; 2003 Oct; 22(4-5):271-8. PubMed ID: 14576989 [TBL] [Abstract][Full Text] [Related]
15. Prevalence and clinico-serological correlations of anti-alpha-enolase, anti-C1q, and anti-dsDNA antibodies in patients with systemic lupus erythematosus. Mosca M; Chimenti D; Pratesi F; Baldini C; Anzilotti C; Bombardieri S; Migliorini P J Rheumatol; 2006 Apr; 33(4):695-7. PubMed ID: 16583471 [TBL] [Abstract][Full Text] [Related]
16. Anti-C1q antibodies are associated with systemic lupus erythematosus global activity but not specifically with nephritis: a controlled study of 126 consecutive patients. Katsumata Y; Miyake K; Kawaguchi Y; Okamoto Y; Kawamoto M; Gono T; Baba S; Hara M; Yamanaka H Arthritis Rheum; 2011 Aug; 63(8):2436-44. PubMed ID: 21506094 [TBL] [Abstract][Full Text] [Related]
17. Prevalence of autoantibodies to ribosomal P proteins in juvenile-onset systemic lupus erythematosus compared with the adult disease. Reichlin M; Broyles TF; Hubscher O; James J; Lehman TA; Palermo R; Stafford HA; Taylor-Albert E; Wolfson-Reichlin M Arthritis Rheum; 1999 Jan; 42(1):69-75. PubMed ID: 9920016 [TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus. Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009 [TBL] [Abstract][Full Text] [Related]
19. Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Sinico RA; Radice A; Ikehata M; Giammarresi G; Corace C; Arrigo G; Bollini B; Li Vecchi M Ann N Y Acad Sci; 2005 Jun; 1050():193-200. PubMed ID: 16014534 [TBL] [Abstract][Full Text] [Related]
20. Autoantibodies against C-reactive protein: clinical associations in systemic lupus erythematosus and primary antiphospholipid syndrome. Figueredo MA; Rodriguez A; Ruiz-Yagüe M; Romero M; Fernandez-Cruz A; Gomez-de la Concha E; Patiño R J Rheumatol; 2006 Oct; 33(10):1980-6. PubMed ID: 17014014 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]